Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug
Go back to Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug| (NASDAQ: ABVX) | Delayed: 106.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.99 | 52 Week High | $ | |||
| Open | $104.59 | 52 Week Low | $ | |||
| Day High | $107.60 | P/E | N/A | |||
| Day Low | $104.15 | EPS | $ | |||
| Volume | 1,732 | |||||

